期刊文献+

SnCl_2还原法生长抑素受体显像剂^(99)Tc^m-octreotide(奥曲肽)的生物活性研究 被引量:2

Biological activity detection of^(99)Tc^m-Octreotide by SnCl_2 deoxidizat ion
下载PDF
导出
摘要 目的 检测SnCl2 还原法生长抑素受体显像剂99Tcm octreotide(奥曲肽 )的生物活性。方法 自制大鼠脑皮质细胞膜 ,进行99Tcm oc treotide与其受体特异性结合能力测定 (TB)、非特异性结合能力测定 (NBS)与竞争性抑制能力测定 ,判断SnCl2 还原法生长抑素受体显像剂99Tcm oc treotide的生物活性。结果 在大鼠脑细胞膜受体固定的条件下99Tcm octreotide与脑细胞膜受体的特异性结合量随99Tcm octreotide的增加而增加 ,但增加的幅度逐渐减低 ,呈饱和趋势 ;非特异性结合量随99Tcm octreotide的增加呈直线上升 ,无饱和趋势 ;竞争抑制实验结果显示 ,随着非标记99Tcm octreotide含量的逐渐增加 ,99Tcm octreotide与脑细胞膜的结合率逐渐降低。结论 本研究获得的99Tcm octreotide具有生长抑素类似物正常的生物学功能。 Objective To detect biological activity of SSTR 99Tc m-Octreotide made by SnCl 2 deoxidization. Methods Choose cell membrane of mice brain cortex and evaluate biological acti vity of somatostatin receptor (SSTR) labeled by 99Tc m-Octreotide by tes ting specific binding ability (TB) of 99Tc m-Octreotide to its receptors and non-specific binding ability (NBS) and competitive inhibiting ability. Results Under stable conditions, the quantity of 99T c m-Octreotide binding specific brain membrane receptors enlarges as 99T c m-Octreotide increases with a trend of saturation. While the quantity of non -specific binding increased without the trend of saturation. Competitive inhibi ting tests demonstrated that the binding rate decreased as non-labeled Octreoti de increased. Conclusions 99Tc m-Octreotide obt ained in this research has certain biological characteristics similar to SSTR.
出处 《中国老年学杂志》 CAS CSCD 北大核心 2004年第11期1048-1049,共2页 Chinese Journal of Gerontology
关键词 ^99Tc^m-octreotide 生长抑素受体 生物活性 Tc m-octreotide Somatostatin r eceptor (SSTR) Biological activity
  • 相关文献

参考文献10

  • 1Bustillo A;Telischi F;Weed D.Octreotide scintigraphy in the head and neck,2004(03).
  • 2Bustillo A;Telischi F.99Tcm-octreotide scintigraphy in the detection of recurrent paragangliomaso,2004(04).
  • 3Nikou GC;Giamarellos-Bourboulis EJ;Grecka P.Effect of octreotide administration on serum interleukin-6 (IL-6) levels of patients with acute edematous pancreatitis[J],2004(56).
  • 4Van Thiel SW;Romijn JA;Biermasz NR.Octreotide long-acting repeatable and lanreotide outogel are equally effective in controlling growth hormone secretion in acromegalic patients[J],2004(04).
  • 5武鸿文,管昌田,梁正路,李云春.肿瘤生长抑素受体显像剂^(99)Tc^m-octreotide的制备及鉴定[J].中华核医学杂志,2000,20(3):112-116. 被引量:16
  • 6Thakurl ML;Kolan HR;Rifat S.Vaproeotide labeled with 99Tcm imaging tumors: Preparation and preliminary,1996.
  • 7张均田.现代药理实验核方法,1998.
  • 8Nielsen S;Mellemkjaer S;Rasmussen LM.Expression of somatostatin receptors on human pituitary adenomas in vivo and ex vivo.4,2001(06).
  • 9Pervez S;Mushtaq AM;Arif M.Technetium-99m direct radio-labeling of lanreotide:A somatostatin analog[J],2001(05).
  • 10叶千春,吴翼伟,范我,江一民,章斌.^(99m)Tc-octreotide的标记及受体分析[J].中国血液流变学杂志,2003,13(1):21-23. 被引量:1

二级参考文献4

共引文献15

同被引文献59

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部